Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
Plants (Basel, Switzerland)
|
November 10, 2020
Soybean Nodule-Associated Non-Rhizobial Bacteria Inhibit Plant Pathogens and Induce Growth Promotion in Tomato
Serkan Tokgöz, Dilip K Lakshman, Mahmoud H Ghozlan, et al.
Regulatory Toxicology and Pharmacology : RTP
|
November 7, 2016
Use of an in vitro human skin permeation assay to assess bioequivalence of two topical cream formulations containing butenafine hydrochloride (1%, w/w)
Amitava Mitra, Nanhye Kim, Darren Spark, et al.
BMC Plant Biology
|
March 13, 2012
Transgenic expression of lactoferrin imparts enhanced resistance to head blight of wheat caused by Fusarium graminearum
Jigang Han, Dilip K Lakshman, Leny C Galvez, et al.
Journal of Pharmaceutical Sciences
|
February 19, 2015
Use of minipig skin biopsy model as an innovative tool to design topical formulation to achieve desired pharmacokinetics in humans
Amitava Mitra, Aquiles Leyes, Kimberly Manser, et al.
Journal of Pharmaceutical Sciences
|
November 29, 2019
Prediction of pH-Dependent Drug-Drug Interactions for Basic Drugs Using Physiologically Based Biopharmaceutics Modeling: Industry Case Studies
Amitava Mitra, Neil Parrott, Neil Miller, et al.
Diseases of Aquatic Organisms
|
April 14, 2006
Immunofluorescent test for simultaneous detection of Edwardsiella ictaluri and Flavobacterium columnare
Victor S Panangalal, Richard A Shelby, Craig A Shoemaker, et al.
Clinical Pharmacology and Therapeutics
|
March 19, 2026
Model-Based Patient Selection and Dosing Strategies for HRAS and PIK3CA Dysregulated HNSCC: A QSP Model for Alpelisib and Tipifarnib Combination
Jaehee Shim, Douglas Chung, Alison Smith, et al.
The AAPS Journal
|
June 8, 2019
"Development of Fixed Dose Combination Products" Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development Strategy
Bart Hens, Maura Corsetti, Marival Bermejo, et al.
Journal of Pharmaceutical Sciences
|
September 22, 2021
Establishing the Bioequivalence Safe Space for Immediate-Release Oral Dosage Forms using Physiologically Based Biopharmaceutics Modeling (PBBM): Case Studies
Tycho Heimbach, Filippos Kesisoglou, Jasmina Novakovic, et al.
Journal of Pharmaceutical Sciences
|
May 8, 2020
Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls: A Workshop Summary Report
Xavier J H Pepin, Neil Parrott, Jennifer Dressman, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
Plants (Basel, Switzerland)
|
November 10, 2020
Soybean Nodule-Associated Non-Rhizobial Bacteria Inhibit Plant Pathogens and Induce Growth Promotion in Tomato
Serkan Tokgöz, Dilip K Lakshman, Mahmoud H Ghozlan, et al.
Regulatory Toxicology and Pharmacology : RTP
|
November 7, 2016
Use of an in vitro human skin permeation assay to assess bioequivalence of two topical cream formulations containing butenafine hydrochloride (1%, w/w)
Amitava Mitra, Nanhye Kim, Darren Spark, et al.
BMC Plant Biology
|
March 13, 2012
Transgenic expression of lactoferrin imparts enhanced resistance to head blight of wheat caused by Fusarium graminearum
Jigang Han, Dilip K Lakshman, Leny C Galvez, et al.
Journal of Pharmaceutical Sciences
|
February 19, 2015
Use of minipig skin biopsy model as an innovative tool to design topical formulation to achieve desired pharmacokinetics in humans
Amitava Mitra, Aquiles Leyes, Kimberly Manser, et al.
Journal of Pharmaceutical Sciences
|
November 29, 2019
Prediction of pH-Dependent Drug-Drug Interactions for Basic Drugs Using Physiologically Based Biopharmaceutics Modeling: Industry Case Studies
Amitava Mitra, Neil Parrott, Neil Miller, et al.
Diseases of Aquatic Organisms
|
April 14, 2006
Immunofluorescent test for simultaneous detection of Edwardsiella ictaluri and Flavobacterium columnare
Victor S Panangalal, Richard A Shelby, Craig A Shoemaker, et al.
Clinical Pharmacology and Therapeutics
|
March 19, 2026
Model-Based Patient Selection and Dosing Strategies for HRAS and PIK3CA Dysregulated HNSCC: A QSP Model for Alpelisib and Tipifarnib Combination
Jaehee Shim, Douglas Chung, Alison Smith, et al.
The AAPS Journal
|
June 8, 2019
"Development of Fixed Dose Combination Products" Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development Strategy
Bart Hens, Maura Corsetti, Marival Bermejo, et al.
Journal of Pharmaceutical Sciences
|
September 22, 2021
Establishing the Bioequivalence Safe Space for Immediate-Release Oral Dosage Forms using Physiologically Based Biopharmaceutics Modeling (PBBM): Case Studies
Tycho Heimbach, Filippos Kesisoglou, Jasmina Novakovic, et al.
Journal of Pharmaceutical Sciences
|
May 8, 2020
Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls: A Workshop Summary Report
Xavier J H Pepin, Neil Parrott, Jennifer Dressman, et al.
Page
of 8